Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome

Abstract

In patients with familial chylomicronemia syndrome, olezarsen may represent a new therapy to reduce plasma triglyceride levels. (Funded by Ionis Pharmaceuticals; Balance ClinicalTrials.gov number, NCT04568434.).